Highest-materiality recent filing
FMC sells 20% stake to Tessenderlo Group for $403M; board seat, standstill
Tessenderlo Group to buy 30.3M shares at $13.30 each, total $403M, for ~20% ownership.
FMC amends credit agreement to allow $200M Corteva IP license refund lien
Amendment No. 7 permits first-priority lien on Rimisoxafen IP to secure up to $200M refund obligation to Corteva Agriscience.
FMC sells Newark, DE property for $114M; plans leaseback, debt paydown
Sale of underutilized buildings and land at Stine Research Center for $114M cash.
FMC closes $1.2B 8% senior secured notes due 2031; proceeds to refinance near-term debt
Issued $1.2B aggregate principal of 8.000% Senior Secured Notes, maturing June 1, 2031.
FMC prices $1.2B 8.000% senior secured notes due 2031 to refinance existing debt
$1.2B aggregate principal amount of 8.000% senior secured notes due 2031, priced at par.
FMC proposes $750M senior secured notes due 2031 to refinance debt
$750M aggregate principal amount of senior secured notes due 2031.
FMC Q1 net loss $281M, Adj EBITDA $72M above guidance; reaffirms FY outlook
Revenue $759M (-4% YoY); GAAP EPS $(2.25); adj EPS $(0.23); adj EBITDA $72M (-40%).
FMC director Dirk Kempthorne dies; shareholders reject supermajority elimination proposals
Director Dirk Kempthorne, board member since 2009, passed away.
FMC Corp. amends credit agreement, adds secured leverage covenant and obtains waiver for Q1 2026
Amendment No. 6 to Fifth Amended and Restated Credit Agreement dated April 16, 2026.
FMC explores strategic options including sale; Q4 net loss $1.72B on impairment
Board authorized exploration of strategic options including a sale to unlock shareholder value.
FMC announces Project Foundation restructuring with $560-635M charges; goodwill impairment expected
Project Foundation to deliver $175M+ annual run-rate savings by end-2027; exits high-cost plants, Asia cuts.
FMC amends credit agreement, extends covenant relief through 2028; adds springing lien trigger
Covenant relief period extended to earlier of Dec 31, 2028 or notice; leverage ratio steps down from 6.00x to 3.75x.
FMC director DiSilvestro resigns immediately due to CFO role at Keurig Dr Pepper
Anthony DiSilvestro resigned from FMC's Board and all committees effective Dec. 3, 2025.
FMC Q3 revenue -49% YoY to $542M; cuts dividend to $0.08/share
GAAP net loss $569M ($4.52/diluted share) vs loss of $65M in Q3 2024, driven by $510M India-related charges.
FMC President Ronaldo Pereira to depart by mutual agreement effective Dec 15
Ronaldo Pereira steps down as President of FMC, effective December 15, 2025.
FMC Q2 adjusted EPS $0.69 +10% YoY; announces divestiture of India commercial business
Q2 revenue $1.05B (+1% YoY), organic +2%; GAAP net income $67M ($0.53/diluted share) down 77% due to prior-year tax gains.
FMC issues $750M of 8.450% subordinated notes due 2055 to refinance near-term debt
Sold $750M aggregate principal of 8.450% Fixed-to-Fixed Reset Rate Subordinated Notes due Nov 1, 2055.
FMC Corp issues $750M of 8.450% subordinated notes due 2055
$750M aggregate principal of 8.450% Fixed-to-Fixed Reset Rate Subordinated Notes due 2055.
FMC Q1 revenue down 14% to $791M; GAAP EPS -$0.12; reaffirms FY guidance
Q1 revenue $791M (-14% YoY, -10% organic); GAAP net loss $16M ($0.12 loss per share).
FMC 2025 annual meeting results: say-on-pay passes narrowly, supermajority amendment fails
All 13 director nominees elected; vote tallies ranged from ~85M to ~92M for, with 16M broker non-votes.
FMC general counsel Michael Reilly to retire; Sara Velazquez Ponessa named successor
Michael F. Reilly retiring as EVP, General Counsel, Chief Compliance Officer and Secretary effective June 1, 2025; full retirement July 1, 2025.
FMC extends $2.0B revolver maturity from June 2027 to June 2028
Amendment No. 4 extends termination date of $2.0B revolving credit facility to June 17, 2028.
FMC Q4 revenue up 7% to $1.22B; adj EPS $1.79; FY24 cash flow surges; 2025 outlook flat
Q4 revenue $1.22B (+7% YoY, +12% organic); adj EBITDA $339M (+33%), $3M above guidance midpoint.
FMC extends covenant relief period to Dec 2027, amends leverage/interest coverage thresholds
Covenant Relief Period Termination Date extended to December 31, 2027.
FMC Corp elects Anthony DiSilvestro to Board of Directors
Anthony DiSilvestro elected to FMC board effective December 12, 2024.
FMC adopts new executive severance plan with 2x-3x multiples for CEO; 7 named officers
Plan covers CEO Brondeau (non-CIC multiple 2, CIC multiple 3), CFO Sandifer, President Pereira, and four other EVPs.
FMC Q3 2024 beats; revenue $1.07B, adj EPS $0.69, reaffirms FY guidance adjusted for GSS sale
Revenue $1.07B (+9% YoY, organic +12%); volume up 17% offset by price -5% and FX -3%.
FMC Q2 revenue up 2%, adjusted EPS $0.63 (+26% YoY); lowers full-year guidance
Q2 revenue $1.04B (+2% YoY); GAAP net income $295M ($2.35 EPS) boosted by Swiss tax incentives.
FMC elects John M. Raines to board of directors effective July 15, 2024
John M. Raines elected to FMC board, effective July 15, 2024; appointed to Audit and Sustainability Committees.
FMC sells Global Specialty Solutions to Envu for $350M; proceeds to debt reduction
Purchase price $350M, subject to working capital adjustment.
FMC appoints Pierre Brondeau as CEO; Mark Douglas steps down, guidance reaffirmed
Pierre Brondeau appointed CEO and Chairman, effective June 11, 2024; succeeds Mark Douglas who resigned as President and CEO.
FMC Q1 revenue $918M (-32% YoY); adjusted EPS $0.36 (-80%); maintains FY outlook
Revenue $918M, down 32% YoY (31% organic); volume -27%, price -4%, FX headwind 1%.
FMC annual meeting elects board, ratifies auditor, passes simple majority vote proposal
All 11 director nominees elected; C. Scott Greer received ~91% of votes cast (94.4M for vs 8.8M against).
FMC appoints new CMO and EVP Operations; transformation lead role created
Brian Angeli appointed EVP & CMO effective May 1, succeeds Diane Allemang who retires after 9 years.
FMC updates Project Focus restructuring costs: $180-215M pre-tax charges, 8% workforce cut
Total pre-tax charges estimated $180-215M; severance $85-100M, asset write-offs $80-90M.
FMC Q4 revenue $1.15B, down 29%; adj EPS $1.07 vs $2.38 prior year; FY24 outlook flat EBITDA
Q4 GAAP EPS $8.77 includes one-time tax benefits from Swiss subsidiary tax incentives.
FMC launches 'Project Focus' restructuring; targets $150M+ annual savings by end 2025
Program aims to deliver $50-75M in adjusted EBITDA contribution in 2024 and $150M+ annual run-rate savings by end 2025.
FMC unveils strategic plan: 2024 rev $4.65-$4.85B, 2026 rev $5.5-$6.0B, asset review
Preliminary 2024 outlook: revenue $4.65B-$4.85B, adj EBITDA $1.025B-$1.125B, FCF conversion >100%.
FMC outlines strategic growth plan; sees 2024 revenue $4.65-4.85B, adj. EBITDA $1.025-1.125B
2024 revenue guidance $4.65-4.85B (midpoint +3% vs latest 2023); adj. EBITDA $1.025-1.125B (midpoint +8%).
FMC amends credit agreement; leverage ratio covenant raised to 6.5x through mid-2024
Maximum leverage ratio raised to 6.5x through June 30, 2024, stepping down to 3.75x by Sept 30, 2025.
FMC Q3 revenue down 29% YoY to $982M, posts GAAP loss, cuts full-year EPS and FCF guidance
GAAP net loss of $4M ($0.03 loss per diluted share), down 103% vs Q3 2022.
FMC cuts Q3 outlook to $982M revenue, $0.44 adj EPS; full year guide reduced
Q3 revenue expected at $982M, adjusted EBITDA $175M, adjusted EPS $0.44 (down from prior guidance).
FMC Q2 revenue falls 30% to $1.01B; GAAP EPS $0.24, down 77% YoY; full-year outlook lowered
Revenue $1.01B, down 30% vs Q2 2022; organic decline 28%; volume down 31%, price up 3%.
FMC elects Dr. Patricia Verduin to Board of Directors effective July 17, 2023
Verduin appointed to Compensation & Organization and Sustainability Committees.
FMC slashes Q2 and FY 2023 guidance on abrupt channel inventory cuts
Q2 revenue expected at $1.00-$1.03B; adjusted EBITDA $185-$190M, down sharply.
FMC amends credit agreement to raise max leverage ratio temporarily to 4.00x through Q1 2024
Max leverage ratio increased to 4.00x for fiscal quarters June 30, 2023 through March 31, 2024.
FMC issues $1.5B in senior notes across three tranches maturing 2026, 2033, 2053
Issued $500M 5.150% Senior Notes due May 18, 2026, $500M 5.650% Notes due 2033, $500M 6.375% Notes due 2053.
FMC Q1 adj EPS $1.77 beats guidance; raises FY adj EBITDA and EPS outlook
Revenue $1.34B flat YoY, up 4% organically; GAAP EPS $1.55 down 6%; adjusted EPS $1.77 down 6% but $0.02 above guidance midpoint.
FMC stockholders approve 2023 Incentive Stock Plan, elect directors, ratify KPMG
2023 Incentive Stock Plan approved with 98,337,131 for, 6,825,120 against; becomes effective April 27, 2023.
FMC director Vincent Volpe to retire, not standing for re-election at 2023 annual meeting
Vincent R. Volpe, Jr. will not stand for re-election to FMC's Board at the 2023 Annual Meeting.
FMC Corporation (the “ Company ”) announced the passing of Dirk A. Kempthorne, a member of our board of directors (the “ Board ”) since 2009.
On April 22, 2025, the Company announced that Sara Velazquez Ponessa has been named Executive Vice President, General Counsel and Corporate Secretary succeeding Mr. Reilly, effective June 1, 2025.
On April 22, 2025, FMC Corporation (“FMC” or the “Company”) announced that Mr. Michael F. Reilly will retire from his positions as Executive Vice President, General Counsel, Chief Compliance Officer and Secretary of the Company effective June 1, 2025, and retire fully from the Company effective July 1, 2025.
The Board of Directors of FMC Corporation (“Company”) has elected John M. Raines as a director of the Company effective July 15, 2024.
He succeeds Mark A. Douglas, who has stepped down from his roles as President and Chief Executive Officer and resigned as a member of the Board.
The Board of Directors (the “Board”) of FMC Corporation (the “Company”) has appointed Pierre R. Brondeau as Chief Executive Officer in addition to his role as Chairman of the Board.
In addition, the Board has appointed Ronaldo Pereira to the role of President of the Company.
The Board of Directors of FMC Corporation (“Company”) has elected Patricia Verduin, Ph.D., as a director of the Company effective July 17, 2023.
On February 23, 2023, Vincent R. Volpe, Jr. informed FMC Corporation (“FMC” or the “Company”) that he will not be standing for re-election to FMC’s Board of Directors (the “Board”) at the 2023 Annual Meeting.
On December 14, 2022, FMC Corporation (“FMC” or the “Company”) announced that Dr. Kathleen Shelton will retire from her position as Executive Vice President and Chief Technology Officer (“CTO”) of the Company effective March 31, 2023.
Max materiality 0.95 · Median 0.65 · Most common event earnings